Perturbed hippocampal synaptic inhibition and γ-oscillations in a neuroligin-4 knockout mouse model of autism by Hammer, Matthieu et al.
ReportPerturbed Hippocampal Synaptic Inhibition and g-
Oscillations in a Neuroligin-4 KnockoutMouseModel
of AutismGraphical AbstractHighlightsd Nlgn4 KO alters the composition of perisomatic inhibitory
synapses in hippocampus
d Inhibitory synaptic transmission is impaired in Nlgn4 KO
hippocampal area CA3
d Nlgn4 KO strongly perturbs oscillatory network activity in
hippocampal area CA3
d Altered GABAergic signaling may link Nlgn4 loss-of-function
mutations to autismHammer et al., 2015, Cell Reports 13, 516–523
October 20, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.09.011Authors
Matthieu Hammer, Dilja Krueger-Burg,
Liam Patrick Tuffy, ..., Frederique
Varoqueaux, Jeong-Seop Rhee, Nils
Brose
Correspondence
rhee@em.mpg.de (J.-S.R.),
brose@em.mpg.de (N.B.)
In Brief
Hammer et al. show that deletion of
autism-associated Nlgn4 alters the
composition of mouse hippocampal
perisomatic inhibitory synapses and
inhibitory synaptic transmission. Strongly
perturbed g-oscillations in area CA3 of
Nlgn4 KO mice may link Nlgn4 loss to
cognitive dysfunction.
Cell Reports
ReportPerturbed Hippocampal Synaptic Inhibition
and g-Oscillations in a Neuroligin-4
Knockout Mouse Model of Autism
Matthieu Hammer,1,4 Dilja Krueger-Burg,1,4 Liam Patrick Tuffy,1 Benjamin Hillman Cooper,1 Holger Taschenberger,1
Sarit Pati Goswami,3 Hannelore Ehrenreich,2 Peter Jonas,3 Frederique Varoqueaux,1,5 Jeong-Seop Rhee,1,*
and Nils Brose1,*
1Department ofMolecular Neurobiology, Max Planck Institute of Experimental Medicine, Hermann-Rein-Straße 3, 37075Go¨ttingen, Germany
2Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Straße 3, 37075 Go¨ttingen, Germany
3Institute of Science and Technology Austria, Am Campus 1, 3400 Klosterneuburg, Austria
4Co-first author
5Present address: Department of Fundamental Neurosciences, University of Lausanne, Rue du Bugnon 9, 1005 Lausanne, Switzerland
*Correspondence: rhee@em.mpg.de (J.-S.R.), brose@em.mpg.de (N.B.)
http://dx.doi.org/10.1016/j.celrep.2015.09.011
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARY
Loss-of-function mutations in the synaptic adhesion
protein Neuroligin-4 are among the most common
genetic abnormalities associated with autism spec-
trum disorders, but little is known about the function
of Neuroligin-4 and the consequences of its loss. We
assessed synaptic and network characteristics in
Neuroligin-4 knockout mice, focusing on the hippo-
campus as a model brain region with a critical role
in cognition and memory, and found that Neuroli-
gin-4 deletion causes subtle defects of the protein
composition and function of GABAergic synapses
in the hippocampal CA3 region. Interestingly, these
subtle synaptic changes are accompanied by
pronounced perturbations of g-oscillatory network
activity, which has been implicated in cognitive
function and is altered in multiple psychiatric and
neurodevelopmental disorders. Our data provide
important insights into the mechanisms by which
Neuroligin-4-dependent GABAergic synapses may
contribute to autism phenotypes and indicate new
strategies for therapeutic approaches.
INTRODUCTION
Autism spectrum disorders (ASDs) are among the most preva-
lent neuropsychiatric disorders, with a high heritability that indi-
cates a major role of genetic causes (Chen et al., 2015). Indeed,
numerous ASD-associated genetic abnormalities, including
monogenic heritable forms of ASD, have been identified, and
many of these affect proteins that determine the structure and
function of neuronal synapses, which led to the notion that
ASD may be a synaptopathy (Kleijer et al., 2014; Zoghbi,
2003). Among the most common monogenic causes associated
with ASD are mutations in the NLGN4 gene (Jamain et al., 2003;516 Cell Reports 13, 516–523, October 20, 2015 ª2015 The AuthorsLaumonnier et al., 2004), which encodes amember of the Neuro-
ligin (Nlgn) family of synaptic cell adhesion proteins (Krueger
et al., 2012). More than 50 mutations in NLGN4 have been iden-
tified in individuals with ASD (Chanda et al., 2015; Kleijer et al.,
2014; S€udhof, 2008), most of which lead to a loss of function
(Zhang et al., 2009). Corroborating this, Nlgn4 knockout (KO)
mice show behavioral changes reminiscent of the core symp-
toms of ASD, including impairments in social interactions and
communication as well as repetitive behaviors and interests
(El-Kordi et al., 2013; Jamain et al., 2008; Ju et al., 2014).
Rodent Nlgn4 is expressed throughout the CNS and localizes
specifically to inhibitory synapses in retina, brainstem, and spinal
cord (Hoon et al., 2011). Like its homolog Nlgn2, Nlgn4 can acti-
vate the signaling protein Collybistin (CB) and thereby recruit the
scaffold protein Gephyrin (GPH) and inhibitory neurotransmitter
receptors to nascent synapses (Hoon et al., 2011). Correspond-
ingly, Nlgn4 deletion in mice causes aberrant inhibitory neuro-
transmission at retinal synapses (Hoon et al., 2011). While these
findings are consistent with the notion that alterations in the bal-
ance of excitatory and inhibitory synaptic transmission play a
role in ASD (Rubenstein and Merzenich, 2003; Yizhar et al.,
2011), only minimal information is available on the function of
Nlgn4 in forebrain regions relevant to ASD symptoms and phe-
notypes. We addressed this issue by assessing synaptic and
network characteristics in Nlgn4 KO mice, focusing on the hip-
pocampus as a model brain region with a key role in cognition
and memory. Our data demonstrate that Nlgn4 co-determines
the structure and function of perisomatic inhibitory synapses in
hippocampal area CA3, and that the subtle synaptic conse-
quences of Nlgn4 loss can have dramatic consequences on
network functions related to cognition.
RESULTS
Nlgn4 Expression in the Mouse Hippocampus
As prior investigations of Nlgn4 expression were restricted to
retina and brainstem (Hoon et al., 2011), we first characterized
the expression of Nlgn4 in the mouse hippocampus, taking
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Figure 1. Nlgn4 Expression in the Hippocampus
(A) (Top) Assessment of Nlgn4 promoter activity using the b-galactosidase
reporter expressed by the gene trap in the Nlgn4 KO line (Jamain et al., 2008)
and X-gal staining reveal expression of the reporter throughout the hippo-
campus. (Bottom) WT control shows a lack of X-gal staining in the absence of
b-galactosidase.
(B–D) Nlgn4 levels in WT hippocampal CA1 and CA3 regions, dentate gyrus
(DG), and brainstem (BS). Representative Nlgn4 immunoblot (B), corre-
sponding protein loading (C, Memcode stain), and quantification (D) are shown
(n = 5 animals).advantage of a gene trap in the Nlgn4 KO that leads to the
expression of b-galactosidase under the control of the Nlgn4
promoter (Jamain et al., 2008). b-galactosidase activity was
observed in all discernible cell types throughout the juvenile
(3 weeks old; Figure S1A) and adult hippocampus (8–12 weeks
old; Figure 1A), and immunoblotting of tissue dissected from
areas CA1, CA3, and the dentate gyrus (DG) showed that
Nlgn4 protein is expressed at equal levels in all subregions of
the adult hippocampus and at levels comparable to those in
brainstem (Figures 1B–1D). While Nlgn4 in retina, brainstem,
and spinal cord is specifically detectable at inhibitory synapses
by immunostaining (Hoon et al., 2011), we failed to clearly detect
Nlgn4 expression in the hippocampus and other forebrain areas
by immunostaining, despite testing multiple antibodies and a
wide array of fixation, antigen-retrieval, and staining protocols.
In all cases, the Nlgn4 immunolabeling intensity in forebrain
was much lower than in brainstem despite equal protein levels
(Figures 1B and 1D), possibly due to differential posttranslational
modifications of the Nlgn4 protein. Accordingly, we instead
sought to determine the synapse specificity of Nlgn4 function
by investigating the consequences of its deletion.
Nlgn Isoform Expression in Nlgn4 KO Hippocampus
We first assessed the effect of Nlgn4 KO on synapse numbers
and composition in the hippocampus. In immunoblot analyses
of synaptosomes (Table S1) prepared from whole hippocampi
of wild-type (WT) and Nlgn4 KOmice, we detected no significant
differences in the levels of key components of inhibitory or excit-
atory synapses, indicating that any changes that might occur
upon Nlgn4 loss must be too local or layer specific to be detect-Cable in tissue homogenates that include all hippocampal regions.
Interestingly, we observed a significant increase in the Nlgn2/
Nlgn1 ratio in synaptosomes from Nlgn4 KOs, resulting from a
modest increase in Nlgn2 levels and a decrease in Nlgn1 levels
(Table S1). These changes indicate a possible compensatory
role of other Nlgn isoforms in the absence of Nlgn4, most notably
of Nlgn2, which has the same biochemical characteristics as
Nlgn4 (Hoon et al., 2011). A corresponding upregulation of
Nlgn4 upon loss of Nlgn2 was detected previously in inhibitory
retinal synapses (Hoon et al., 2011).
Inhibitory Synapses in the CA3 Stratum Pyramidale of
Nlgn4 KO Hippocampus
To determine whether Nlgn4 KO causes local or layer-specific
changes of synaptic protein levels in the hippocampus, we em-
ployed an immunostaining approach. It was shown previously
that Nlgn4 KO leads to alterations in components of inhibitory
postsynapses in the retina (Hoon et al., 2011). We thus per-
formed immunostaining for GPH, a scaffold protein of inhibitory
postsynapses, and for the GABAA receptor g2 subunit (GABAA
Rg2), a marker of mature inhibitory synapses, in the hippocam-
pus of adult mice (Figures 2A and 2B). The density of GPH-
and GABAARg2-containing puncta in the CA3 region was
decreased by 32% and 34%, respectively, in the perisomatic re-
gion of stratum pyramidale neurons of Nlgn4 KOs (Figures 2B
and 2C). GPH puncta per 10 mm cell perimeter were as follows:
WT, 15.8 ± 0.84; KO, 10.8 ± 0.88; n = 12, p < 0.001; and
GABAARg2 puncta per 10 mm cell perimeter were as follows:
WT, 19.7 ± 1.72; KO, 13.1 ± 1.98; n = 12, p < 0.05. No alterations
in the density of GPH or GABAARg2 puncta were observed in
other CA3 layers (Figures 2D and 2E). Similar reductions in
GPH and GABAARg2 puncta in CA3 stratum pyramidale were
observed at a juvenile time point (3 weeks old; Figures S1B–
S1D), indicating that the postsynaptic changes at inhibitory syn-
apses caused by Nlgn4 KO arise early and are maintained after
initial synapse formation.
To assess whether these changes are due to a decrease in the
number of inhibitory synapses, we stained for the vesicular inhib-
itory amino acid transporter (VIAAT), amarker of inhibitory presy-
napses. No alterations in the number of VIAAT puncta were
observed in the perisomatic region of the CA3 stratum pyrami-
dale of Nlgn4 KOs (Figures 2B and 2C) or in any other layer (Fig-
ure 2F), indicating that Nlgn4 KO does not cause an overall loss
of presynaptic innervation or decrease in the number of inhibitory
synapses. Instead, it causes a defect in the synaptic recruitment
of GPH and GABAARs, which also is seen upon KO of the Nlgn4-
related Nlgn2 isoform (Poulopoulos et al., 2009; Soykan et al.,
2014).
Excitatory Synapses in the CA3 Stratum Pyramidale of
Nlgn4 KO Hippocampus
To test whether Nlgn4 KO also affects excitatory synapses in the
hippocampus, we stained for the excitatory synapse marker
PSD-95. No alterations in the very sparse PSD-95 puncta density
in the CA3 stratum pyramidale were observed, confirming that
the changes in this layer are specific to inhibitory synapses (Fig-
ure S2). Similarly, no changes were observed in CA3 stratum ori-
ens or stratum radiatum (Figure S2), while a small but significantell Reports 13, 516–523, October 20, 2015 ª2015 The Authors 517
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Figure 2. Inhibitory Synapses in the CA3
Stratum Pyramidale of Nlgn4 KOs
(A) Images show GPH, GABAARg2, and VIAAT
immunoreactivity in CA3 of WT mice. Scale bar,
10 mm.
(B) High-magnification images show GPH,
GABAARg2, and VIAAT immunoreactivity in CA3
stratum pyramidale of WT and Nlgn4 KO mice.
Scale bar, 5 mm.
(C) Quantification of GPH, GABAARg2, and VIAAT
puncta in the perisomatic area of pyramidal cells in
CA3 is shown (puncta per 10 mm perimeter).
(D–F) Quantifications of GPH (D), GABAAR g2 (E),
and VIAAT (F) puncta in the stratum oriens, stratum
lucidum, and stratum radiatum of CA3 are shown
(puncta per 100 mm2).
S.O., stratum oriens; S.P., stratum pyramidale;
S.L., stratum lucidum; S.R., stratum radiatum.
Error bars represent SEM; n = 12 pairs ofmice; *p <
0.05, ***p < 0.001.decrease in the number of PSD-95 puncta was found in stratum
lucidum (Figure S2B). These findings show that Nlgn4 KO may
have differential effects even in different layers of the same brain
region.
Inhibitory Synaptic Transmission in the CA3 Region of
Nlgn4 KO Hippocampus
We next performed patch-clamp recordings fromCA3 pyramidal
cells in acute hippocampal slices of juvenile mice (post-natal day
P12–P26) to test whether the altered composition of periso-
matic inhibitory postsynapses in Nlgn4 KOs is accompanied by
changes in synaptic transmission. We observed a significant
decrease in the peak amplitude of spontaneous inhibitory post-
synaptic currents (sIPSCs; Figures 3A, 3C, and 3F; WT, 45.2 ±
3.3 pA; KO, 31.0 ± 3.4 pA; n = 22, p < 0.01), as well as a slight
but significant decrease in the sIPSC frequency (Figures 3A518 Cell Reports 13, 516–523, October 20, 2015 ª2015 The Authorsand 3C; WT, 6.4 ± 0.5 Hz; KO, 4.9 ±
0.5 Hz; n = 22, p < 0.05). No significant
changes were observed in the amplitude
or frequency ofminiature IPSCs (mIPSCs;
Figures 3B and 3D–3F; amplitude: WT,
32.2 ± 2.3 pA; KO, 28.2 ± 2.4 pA; n = 22;
frequency: WT, 4.3 ± 0.4 Hz; KO, 4.0 ±
0.5 Hz; n = 22, not significant). The ampli-
tude and frequency of spontaneous and
miniature excitatory postsynaptic cur-
rents (sEPSCs and mEPSCs) remained
unchanged (Figure S3), confirming that
Nlgn4 KO affects primarily inhibitory syn-
apses in area CA3 of the hippocampus.
Interestingly, analyses of sIPSC and
mIPSC kinetics revealed a significant
increase in the rise times (RTs) (Figure 3G)
and decay time constants (Figure 3H)
of sIPSCs (20%–80% RT: WT, 0.71 ±
0.05 ms; KO, 0.89 ± 0.06 ms; n = 22,
p < 0.05; decay time constant: WT,
13.3 ± 0.9 ms; KO, 16.4 ± 0.9 ms; n =22, p < 0.05) and mIPSCs (20%–80% RT: WT, 0.64 ± 0.05 ms;
KO, 0.81 ± 0.06 ms; n = 22, p < 0.05; decay time constant:
WT, 12.2 ± 0.7 ms; KO, 14.6 ± 0.8 ms; n = 22, p < 0.05). Among
other possibilities, this slowing of the average time course of
sIPSCs and mIPSCs could arise from a selective weakening of
the inputs with the fastest kinetics, i.e., those that originate
from perisomatic synapses (Kerti-Szigeti et al., 2014). We there-
fore re-analyzed two subsets of mIPSCs with RTs%400 and%
300 ms, respectively (Figures 3I and 3J). This analysis revealed a
decrease in the amplitude of the fastest mIPSCs (RT% 400 ms:
WT, 30.9 ± 3.1 pA; KO, 22.5 ± 3.1 pA; n = 22, p = 0.06; RT %
300 ms: WT, 24.2 ± 2.6 pA; KO, 17.2 ± 2.0 pA; n = 22, p < 0.05)
and a decrease in the fraction of fast events among the total
number of events analyzed (RT % 400 ms: WT, 18.1% ± 3.6%;
KO, 8.2% ± 2.1%; n = 22, p < 0.05; RT % 300 ms: WT, 6.3% ±
1.7%; KO, 2.6% ± 0.6%; n = 22, p = 0.05).
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Figure 3. Inhibitory Synaptic Transmission in CA3 Pyramidal Cells of
Nlgn4 KOs
(A and B) Recordings of sIPSCs (A) and mIPSCs (B) from CA3 pyramidal
neurons in acute hippocampal slices from WT and Nlgn4 KO mice are shown.
(C and D) Comparisons of the average cumulative distribution of sIPSC am-
plitudes (C) and mIPSC amplitudes (D) are shown.
(E–H) Quantifications of the average frequency (E), peak amplitude (F),
20%–80% RT (G), and decay time constant (H) of sIPSCs and mIPSCs are
shown.
(I) Normalized average sIPSCs and mIPSCs in WT (black) and Nlgn4 KO (red)
mice are shown.
(J) Normalized average current of mIPSCs having RTs%400 (left) and%300 ms
(right) in WT (black) and Nlgn4 KO (red) mice is shown.
Error bars represent SEM; n = 22 cells per genotype; *p < 0.05.
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Figure 4. g-Oscillations in the CA3 Region of Nlgn4 KOs
(A) Traces of g-oscillations induced by 100 nM kainate in acute CA3 hippo-
campal slices from WT and Nlgn4 KO mice are shown.
(B) Representative power spectrum of g-oscillations inWT (gray) andNlgn4 KO
(red) mice is shown.
(C and D) Quantifications of the power (C) and frequency (D) of the maximum
peak are shown.
Error bars represent SEM; n = 6 mice per genotype (average of three slices/
animal); ***p < 0.001.
CPerturbed g-Oscillations in the CA3 Region of Nlgn4 KO
Hippocampus
Inhibitory connections in the hippocampus contribute substan-
tially to the generation of synchronized network activity, particu-
larly in the g frequency range of 30–80 Hz (Bartos et al., 2007).
These g-oscillations, in turn, have been implicated in the cogni-
tive functions mediated by the hippocampus (Uhlhaas and
Singer, 2012). To investigate whether g-oscillations are altered
in Nlgn4 KOs, oscillatory activity was induced pharmacologically
in acute hippocampal slices by kainate application (100 nM) (Fi-
sahn et al., 2004). This treatment yielded long-lasting and stable
oscillations within 10 min of drug application (Figure 4A). Power
spectrum analyses revealed a substantial reduction of the power
of oscillations in Nlgn4 KOs (Figures 4B and 4C; WT peak, 119.8
± 8.4 mV2/Hz; KO peak, 43.9 ± 13.0 mV2/Hz; n = 6 pairs of WT and
KO animals, three slices per animal, p < 0.001), while the fre-
quency was not altered (Figure 4D; WT, 33.8 ± 1.1 Hz; KO,
33.6 ± 1.4 Hz; n = 6 pairs of WT and KO animals, three slices
per animal). These findings are consistent with the notion that
Nlgn4 loss may cause some of the cognitive impairments asso-
ciated with ASD by perturbing oscillatory activity in the hippo-
campus and potentially in other brain regions, such as the
prefrontal cortex.
DISCUSSION
This study shows that Nlgn4 loss subtly alters the composition
of perisomatic inhibitory synapses and inhibitory synapticell Reports 13, 516–523, October 20, 2015 ª2015 The Authors 519
transmission and strongly perturbs g-oscillations in the mouse
hippocampus CA3 region. The following three key conclusions
arise from our findings: (1) Nlgn4, like Nlgn2, functions primarily
at inhibitory synapses in this region, likely at perisomatic synap-
ses originating from parvalbumin (PV)-positive interneurons; (2)
subtle local changes in synapse function resulting from ASD-
associated Nlgn4 mutations can accumulate to yield pro-
nounced perturbations in global network activity; and (3) the
resulting alterations in synchronized oscillatory activity may
represent an important mechanism linking loss of Nlgn4 function
to cognitive dysfunction in individuals with Nlgn4 mutations.
A first important result of our study is that Nlgn4 has a synapse
type-specific function in themouse hippocampus.We found that
Nlgn4 KO causes a selective loss of components of inhibitory
postsynapses in the stratum pyramidale of the hippocampal
CA3 region (Figures 2 and S2); specific reductions in the
amplitude and frequency of sIPSCs, but not sEPSCs, in CA3
pyramidal cells (Figures 3 and S3); and an upregulation of the
Nlgn2/Nlgn1 ratio, indicating a compensation of Nlgn4 loss by
the functionally related Nlgn2 (Table S1). These observations
corroborate earlier cell biological studies, which showed that
Nlgn4, like Nlgn2, can recruit GABAARs to membranes by CB
activation and GPH binding; that Nlgn4 is localized to inhibitory
postsynapses in retina, brainstem, and spinal cord; and that
loss of Nlgn4 in retina causes a selective upregulation of Nlgn2
(Hoon et al., 2011). Interestingly, our findings are highly reminis-
cent of the effects of Nlgn2 KO (Jedlicka et al., 2011; Poulopou-
los et al., 2009; Soykan et al., 2014), and together they indicate
that Nlgn4, like Nlgn2, may function primarily at inhibitory
synapses.
Whether Nlgn4 also plays a role at excitatory synapses is un-
clear, at least for the mouse brain. Excitatory synapses in mouse
retina, brainstem, and spinal cord do not contain Nlgn4 (Hoon
et al., 2011). Extrapolating from this observation, which is neces-
sary due to detectability limitations, and considering that we
found here that Nlgn4 loss affects only inhibitory, but not excit-
atory, transmission (Figures 2, 3, 4, and S3), it appears that
Nlgn4 functions specifically at inhibitory synapses in the mouse
hippocampus and that the slight decrease in the PSD-95 puncta
density in the CA3 stratum lucidum of Nlgn4 KOs (Figure S2) may
be a result of a compensatory homeostatic downregulation in
response to the perturbation of inhibitory signaling. It is possible
that a different scenario arises in mouse somatosensory cortex,
where Nlgn4 KOwas reported to affect both inhibitory and excit-
atory synapses (Delattre et al., 2013), but the present study did
not provide supporting evidence.
The issue of synapse specificity of human NLGN4 is more
complex. Of all Nlgns, Nlgn4/NLGN4 are least conserved be-
tween mouse and human (Bolliger et al., 2008; Jamain et al.,
2008), and the subcellular localization of NLGN4 in the human
brain is unknown. Expression of human NLGN4 in cultured
mouse hippocampal neurons suppresses excitatory synaptic
responses (Chanda et al., 2015), while NLGN4 expression in
rat organotypic hippocampal slice cultures has the opposite ef-
fect (Bemben et al., 2015), indicating that NLGN4 can act at
excitatory synapses if exogenously expressed. However, Nlgns
have promiscuous synaptogenic effects when overexpressed
in neurons (Chih et al., 2005), and Nlgn heterodimerization can520 Cell Reports 13, 516–523, October 20, 2015 ª2015 The Authorsfurther confound readouts of Nlgn specificity in overexpressing
WT neurons (Poulopoulos et al., 2012). Final conclusions on
the synapse specificity of human NLGN4 thus only are possible
once its synaptic localization is known. Nevertheless, the con-
servation of GPH and, partially, of CB-binding sites between
the mouse and human variants (Bolliger et al., 2008; Jamain
et al., 2008), along with the fact that Nlgn4 KO mice show
ASD-related phenotypes that are similar to the symptoms of
NLGN4-deficient patients (Jamain et al., 2008), indicates that
at least some key functions are conserved between mouse
Nlgn4 and human NLGN4, including actions at inhibitory synap-
ses in vivo.
Interestingly, our data indicate that the effects of Nlgn4 KO in
hippocampal area CA3 are restricted to a highly specific subset
of perisomatic inhibitory synapses in the stratum pyramidale.
This layer specificity is reminiscent of the effects of Nlgn2 KO
(Poulopoulos et al., 2009) and shows that these synapses
depend on Nlgn4 while other synapses do not, likely because
other adhesion systems govern their formation, maturation,
and maintenance. This also is reflected by our electrophysiolog-
ical analyses, which revealed decreased amplitudes and fre-
quencies of sIPSCs along with increased sIPSC RTs and decay
time constants in Nlgn4 KO pyramidal cells of the CA3 region,
while mIPSCs had primarily slower kinetics and only in the fast-
est events also showed reduced amplitudes (Figure 3). These
data indicate that Nlgn4 KO mainly affects synapses originating
from interneuron subtypes that contribute strongly to sponta-
neous action-potential-driven inputs to somata of CA3 principal
cells, have a low probability of spontaneous synaptic vesicle
fusion (i.e., contribute few mIPSCs), and target principal cell
somata or proximal dendrites—criteria that are met by PV-posi-
tive basket cells in several brain regions (Goswami et al., 2012;
Katona et al., 2014; Lapray et al., 2012; Pfeffer et al., 2013; Wolff
et al., 2014). Moreover, PV-positive basket cells contribute the
majority of exactly those perisomatic inhibitory inputs of hippo-
campal pyramidal cells (Taka´cs et al., 2015) that are specifically
affected by Nlgn4 KO, and the kainate-induced g-oscillations
that are strongly affected in the Nlgn4 KOs (Figure 4) are highly
dependent on the perisomatic synaptic inhibition generated by
PV-positive interneurons (Bartos et al., 2007; Cardin et al.,
2009; Mann and Paulsen, 2007; Sohal et al., 2009). Together,
these considerations lead us to conclude that Nlgn4 KO mainly
perturbs the inputs of PV-positive interneurons to CA3 principal
cells.
Beyond this notable synapse specificity, the effects of Nlgn4
loss on inhibitory synapses in the hippocampal CA3 region, while
clearly discernible, are relatively subtle even at the affected sub-
set of synapses (Figures 2 and 3). This is perhaps unsurprising
given that Nlgn4 is much less strongly expressed in mouse brain
than other Nlgns (Varoqueaux et al., 2006). Strikingly, however,
despite affecting only an estimated 1.5% of the total inhibitory
synapse population in area CA3, these small changes in sum
appear to cause large perturbations in the overall activity of the
network, as indicated by the pronounced reduction in the power
of the g-oscillations in the Nlgn4 KO. The g-oscillations are
thought to play a key role in the cognitive functions mediated
by the hippocampus (Uhlhaas and Singer, 2012), including sen-
sory processing and memory formation, and they have been
correlated with specific behavior conditions, such as exploratory
behavior (Bragin et al., 1995) and performance during working
memory tasks (Fuchs et al., 2007). Our findings thus provide
an interesting potential mechanism by which seemingly minor
molecular and functional synaptic abnormalities induced by dis-
ease-associated Nlgn4mutationsmay have a substantial impact
on functional psychiatric phenotypes. While further experiments
will be necessary to confirm this hypothesis, such mechanisms
may be of widespread relevance to ASD given the subtle nature
of most neuropathological alterations identified in postmortem
tissue from ASD patients to date (Chen et al., 2015).
Indeed, weaker g-oscillations are observed in several neuro-
psychiatric disorders, including ASD (Maxwell et al., 2015).
There are, thus, striking links between ASD and aberrant g-os-
cillations in human patients on the one hand and between
ASD-related human loss-of-function mutations in NLGN4 and
aberrant GABAergic synaptic transmission and g-oscillations
in a mouse model of ASD-related Nlgn4 loss on the other
hand. These links raise the possibility that the behavioral ab-
normalities due to NLGN4/Nlgn4 loss in ASD patients and
model mice are caused by aberrant GABAergic signaling
and g-oscillatory activity, and may thus be treatable by thera-
pies that target the GABAergic system in the oscillatory cir-
cuitry and restore synchronized network activity in the hippo-
campus and other brain regions.
This scenario may even have more general relevance to ASD
and the development of novel treatments. Indeed, deficient
inhibitory GABAergic signaling and alterations in PV-expressing
interneurons also have been observed in other mouse models of
ASD (Chao et al., 2010; Gogolla et al., 2009; Rothwell et al., 2014;
Tyzio et al., 2014) as well as in postmortem tissue from individ-
uals with ASD (Chen et al., 2015; Voineagu et al., 2011), and
GABAergic signaling is emerging as a key treatment target in
ASD (Braat and Kooy, 2015; Cellot and Cherubini, 2014; Mo¨hler,
2015).
EXPERIMENTAL PROCEDURES
Animals
Experiments were performed on juvenile (P12–P26) or adult (8- to 12-week-
old) male Nlgn4 KOs and male WT littermates on a C57BL/6J background
(see the Supplemental Experimental Procedures). All animal experiments
were approved by the responsible government institution (Niedersa¨chsisches
Landesamt f€ur Verbraucherschutz und Lebensmittelsicherheit).
X-Gal Staining, Immunohistochemistry, and Immunoblotting
X-gal staining was conducted to assess Nlgn4 expression based on a b-galac-
tosidase coding sequence in the gene trap insertion used to generate the
Nlgn4 KO (Jamain et al., 2008). Immunohistochemical analysis of postsynaptic
proteins was performed on methanol-fixed fresh-frozen brain sections. Immu-
nohistochemical analysis of presynaptic proteins was performed on perfusion-
fixed free-floating brain sections. Images were obtained using a TCS-SP5
inverted confocal microscope (Leica Microsystems) and a 633 water immer-
sion objective. For quantification and colocalization experiments, images
were processed using ImageJ. Immunoblotting of tissue from hippocampal
subregions and synaptosomes was conducted according to standard proce-
dures (see the Supplemental Experimental Procedures).
Electrophysiology
Transverse hippocampal slices (300 mm thick) were obtained from juvenile
mice. The sIPSCs, mIPSCs, sEPSCs, and mEPSCs were recorded in CA3 py-Cramidal cells in the whole-cell configuration. The g-oscillations were recorded
in area CA3 as extracellular field potentials under interface conditions (see the
Supplemental Experimental Procedures).
Statistics
Data are presented as mean ± SEM. Statistical significance of differences was
evaluated with the two-tailed unpaired Student’s t test and p < 0.05 was taken
as the level of statistical significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.09.011.
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